92 related articles for article (PubMed ID: 19920048)
1. Safety of binodenoson, a selective adenosine A2A receptor agonist vasodilator pharmacological stress agent, in healthy subjects with mild intermittent asthma.
Murray JJ; Weiler JM; Schwartz LB; Busse WW; Katial RK; Lockey RF; McFadden ER; Pixton GC; Barrett RJ
Circ Cardiovasc Imaging; 2009 Nov; 2(6):492-8. PubMed ID: 19920048
[TBL] [Abstract][Full Text] [Related]
2. Randomized, controlled dose-ranging study of the selective adenosine A2A receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging.
Udelson JE; Heller GV; Wackers FJ; Chai A; Hinchman D; Coleman PS; Dilsizian V; DiCarli M; Hachamovitch R; Johnson JR; Barrett RJ; Gibbons RJ
Circulation; 2004 Feb; 109(4):457-64. PubMed ID: 14734517
[TBL] [Abstract][Full Text] [Related]
3. Effect of ticagrelor on pulmonary function in healthy elderly volunteers and asthma or chronic obstructive pulmonary disease patients.
Butler K; Maya J; Teng R
Curr Med Res Opin; 2013 May; 29(5):569-77. PubMed ID: 23448616
[TBL] [Abstract][Full Text] [Related]
4. Coronary circulation responses to binodenoson, a selective adenosine A2A receptor agonist.
Hodgson JM; Dib N; Kern MJ; Bach RG; Barrett RJ
Am J Cardiol; 2007 Jun; 99(11):1507-12. PubMed ID: 17531571
[TBL] [Abstract][Full Text] [Related]
5. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF
N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090
[TBL] [Abstract][Full Text] [Related]
6. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
[TBL] [Abstract][Full Text] [Related]
7. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
8. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and safety of binodenoson after intravenous dose escalation in healthy volunteers.
Barrett RJ; Lamson MJ; Johnson J; Smith WB
J Nucl Cardiol; 2005; 12(2):166-71. PubMed ID: 15812370
[TBL] [Abstract][Full Text] [Related]
10. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy of ciclesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study.
Niphadkar P; Jagannath K; Joshi JM; Awad N; Boss H; Hellbardt S; Gadgil DA
Clin Ther; 2005 Nov; 27(11):1752-63. PubMed ID: 16368446
[TBL] [Abstract][Full Text] [Related]
12. Mometasone furoate antagonizes AMP-induced bronchoconstriction in patients with mild asthma.
Holgate ST; Arshad H; Stryszak P; Harrison JE
J Allergy Clin Immunol; 2000 May; 105(5):906-11. PubMed ID: 10808170
[TBL] [Abstract][Full Text] [Related]
13. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
Kisicki JC; Fiske K; Lyne A
Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
Medley H; Orozco S; Allen A
Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma.
Busse WW; Casale TB; Murray JJ; Petrocella V; Cox F; Rickard K
Am J Manag Care; 1998 Nov; 4(11):1579-87. PubMed ID: 10338904
[TBL] [Abstract][Full Text] [Related]
16. Tolerability of indacaterol, a novel once-daily beta2-agonist, in patients with asthma: a randomized, placebo-controlled, 28-day safety study.
Yang WH; Martinot JB; Pohunek P; Beier J; Magula D; Cameron R; Owen R; Higgins M
Ann Allergy Asthma Immunol; 2007 Dec; 99(6):555-61. PubMed ID: 18219838
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy).
Storey RF; Becker RC; Harrington RA; Husted S; James SK; Cools F; Steg PG; Khurmi NS; Emanuelsson H; Lim ST; Cannon CP; Katus HA; Wallentin L
Am J Cardiol; 2011 Dec; 108(11):1542-6. PubMed ID: 21890085
[TBL] [Abstract][Full Text] [Related]
18. Trial to evaluate the management of paroxysmal supraventricular tachycardia during an electrophysiology study with tecadenoson.
Ellenbogen KA; O'Neill G; Prystowsky EN; Camm JA; Meng L; Lieu HD; Jerling M; Shreeniwas R; Belardinelli L; Wolff AA;
Circulation; 2005 Jun; 111(24):3202-8. PubMed ID: 15956124
[TBL] [Abstract][Full Text] [Related]
19. Once-daily evening administration of mometasone furoate in asthma treatment initiation.
Bensch GW; Prenner B; Berkowitz R; Galant S; Ramsdell J; Lutsky B
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):533-40. PubMed ID: 16680923
[TBL] [Abstract][Full Text] [Related]
20. Heart rate-lowering efficacy and respiratory safety of ivabradine in patients with obstructive airway disease: a randomized, double-blind, placebo-controlled, crossover study.
Majewski S; Slomka S; Zielinska-Wyderkiewicz E; Ciebiada M; Gorski P
Am J Cardiovasc Drugs; 2012 Jun; 12(3):179-88. PubMed ID: 22409211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
